Accendra Health, Inc.ACHNYSE
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
3Y CAGR+10.4%
5Y CAGR+5.5%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+10.4%/yr
Annual compound
5Y CAGR
+5.5%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM4.98%+941.1%
20240.48%-87.3%
20233.78%+2.1%
20223.70%-12.8%
20214.25%+11.3%
20203.81%+88.1%
20192.03%+170.0%
2018-2.90%-228.9%
20172.25%-21.9%
20162.88%-